When herds overgraze: the cost of conformity in oncology drug development
BMJ Oncology · 2026-01 · 5 (1) · e001089
DOI: 10.1136/bmjonc-2026-001089 ↗Kurz gefasst
Editorial in der Zeitschrift BMJ Oncology, online erschienen am 31.03.2026. Verfasst von Jia Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, NSW, Australia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
In nature, herding reflects adaptive responses to environmental pressure. In predator-dense African savannahs, animals herd defensively for protection. In resource-scarce deserts, herding occurs around limited resources. Herding in oncology drug development reflects these same evolutionary pressures: defensive clustering around promising targets to reduce risk.1 The analysis by Zhang and colleagues2 provides an empirical test of when this adaptive strategy becomes maladaptive.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, NSW, Australia.
- Faculty of Medicine & Health, University of New South Wales, Sydney, NSW, Australia.
- Garvan Institute of Medical Research, Sydney, NSW, Australia.
- Yale University Yale Cancer Center, New Haven, Connecticut, USA.
ORCID-Profile: Jia Liu
Zitieren
APA
Liu, J., & LoRusso, P. (2026). When herds overgraze: the cost of conformity in oncology drug development. BMJ Oncology, 5(1), e001089. https://doi.org/10.1136/bmjonc-2026-001089
Vancouver
Liu J, LoRusso P. When herds overgraze: the cost of conformity in oncology drug development. BMJ Oncology. 2026;5(1):e001089. doi:10.1136/bmjonc-2026-001089
BibTeX
@article{Liu2026,
author = {Liu, Jia and LoRusso, Patricia},
title = {When herds overgraze: the cost of conformity in oncology drug development},
journal = {BMJ Oncology},
year = {2026},
volume = {5},
number = {1},
pages = {e001089},
doi = {10.1136/bmjonc-2026-001089}
}
EUVIMED